NDC 68083-340
ziprasidone mesylate
Ziprasidone Mesylate
ziprasidone mesylate is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Ziprasidone Mesylate.
| Product ID | 68083-340_60bf2a0a-0b8e-4670-8ee0-6d8b0708b1ed |
| NDC | 68083-340 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ziprasidone mesylate |
| Generic Name | Ziprasidone Mesylate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2019-12-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211908 |
| Labeler Name | Gland Pharma Limited |
| Substance Name | ZIPRASIDONE MESYLATE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |